Intelligence Β· Patent portfolio

Eton Pharmaceuticals Patents

Full USPTO pharma patent portfolio for Eton Pharmaceuticals β€” grant dates, expiration, and drug cross-links.

Patents
163
Expiring ≀24m
6

Quick answer

Eton Pharmaceuticals has 163 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 6 expire within 24 months β€” use filters for patent-cliff planning.

Page 3 of 4

  1. US 9029413

    Treatment of viral infections by modulation of host cell metabolic pathways

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 8993117

    Devices with multiple surface functionality

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 8828399

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 8772331

    Small molecule antagonists of bacterial quorum-sensing receptors

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 8747883

    Medical item for long term drug release

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 8568756

    Inhibition of quorum sensing-mediated processes in bacteria

    Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 8551935

    Benefit agent containing delivery particle

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 8535689

    Identification of bacterial autoinducer and use in treating bacterial pathogenicity

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 8481511

    Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 8440618

    Composition for the attachment of implants to collagen or other components of biological tissue

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 8426385

    Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 8389231

    Assays, method and compositions that exploit a mycobacterial iron acquistion pathway in cells

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 8372435

    Modular monolayer coatings for selective attachment of nanoparticles to biomolecules

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 8334377

    Porphyrin catalysts and methods of use thereof

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 8278437

    Hydroxypropyl-sulfobutyl-beta-cyclodextrin, the preparation method, the analytical method, and the pharmacutical application thereof

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 8247443

    Small molecule antagonists of bacterial quorum-sensing receptors

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 8232267

    Porphyrin catalysts and methods of use thereof

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 8221804

    Compositions and methods for enhancing cognitive function

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 8222218

    Cyclopropanated carbohydrates

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 8173362

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 8158677

    Treatment of viral infections by modulation of host cell metabolic pathways

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 8137699

    Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use

    Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 8111019

    Sensing type control circuit for electronic apparatus

    Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 8067355

    Benefit agent containing delivery particles

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 8067089

    Cationic microcapsule particles

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7923041

    Compositions and methods for enhancing cognitive function

    Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7915215

    Fragrance-delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7718600

    IAP binding compounds

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7704510

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7666619

    Compounds and methods for regulating bacterial growth and pathogenesis

    Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7547726

    AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7432093

    Soluble, functional apoptotic protease-activating factor 1 fragments

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7331920

    Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7326542

    Compositions and methods for regulating bacterial pathogenesis

    Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7326695

    Anti-bacterial agents based upon oxoanion binding

    Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7323340

    Compositions and methods for regulating bacterial pathogenesis

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7259278

    Anti-S-phase tubulin ligands

    Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7208612

    Crystals of LuxP and complexes thereof

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7049116

    Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

    Expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  40. US 7026461

    Engineered protein kinases which can utilize nucleotide triphosphate substrates

    Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  41. US 6992063

    Compositions and method for regulating apoptosis

    Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  42. US 6969707

    Peroxynitrite decomposition catalysts and methods of use thereof

    Expires Mon Nov 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  43. US 6942986

    Compositions and methods for regulating bacterial pathogenesis

    Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  44. US 6936435

    Compositions and methods for regulating bacterial pathogenesis

    Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  45. US 6884239

    Ingestible device for the release of substances at distinct locations in alimentary canal

    Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  46. US 6864067

    Compositions and methods for regulating bacterial pathogenesis

    Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  47. US 6844423

    Compositions and methods for regulating bacterial pathogenesis

    Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  48. US 6841661

    Glycopeptide antibacterial compounds, compositions containing same and methods of using same

    Expires Mon Jan 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Eton Pharmaceuticals have?

163 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Eton Pharmaceuticals patents expire?

6 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory